セファロマンニン
セファロマンニン 物理性質
- 融点 :
- 139-141?C
- 沸点 :
- 929.5±65.0 °C(Predicted)
- 比重(密度) :
- 1.36±0.1 g/cm3(Predicted)
- 貯蔵温度 :
- -20°C Freezer
- 溶解性:
- DMSO: 14 mg/mL、可溶
- 酸解離定数(Pka):
- 11.95±0.20(Predicted)
- 外見 :
- 個体
- 色:
- ホワイト～ペールベージュ
- InChIKey:
- DBXFAPJCZABTDR-WBYYIXQISA-N
- CAS データベース:
- 71610-00-9
| メーカー |
製品番号 |
製品説明 |
CAS番号 |
包装 |
価格 |
更新時間 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01CHDASB-00003360 |
セファロマンニン
Cephalomannine |
71610-00-9 |
5mg |
￥59400 |
2024-03-01 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01CHDASB-00003360 |
セファロマンニン
Cephalomannine |
71610-00-9 |
10mg |
￥104000 |
2024-03-01 |
購入 |
|
Sigma-Aldrich Japan
|
PHR2111 |
セファロマンニン Pharmaceutical Secondary Standard; Certified Reference Material
Cephalomannine Pharmaceutical Secondary Standard; Certified Reference Material |
71610-00-9 |
50mg |
￥93400 |
2024-03-01 |
購入 |
|
Sigma-Aldrich Japan
|
C4991 |
セファロマンニン ≥97% (HPLC), solid
Cephalomannine ≥97% (HPLC), solid |
71610-00-9 |
1mg |
￥25800 |
2024-03-01 |
購入 |
|
Sigma-Aldrich Japan
|
1491343 |
セファロマンニン United States Pharmacopeia (USP) Reference Standard
Paclitaxel Related Compound A United States Pharmacopeia (USP) Reference Standard |
71610-00-9 |
20mg |
￥272000 |
2024-03-01 |
購入 |
セファロマンニン 化学特性,用途語,生産方法
化学的特性
Off-White Solid
天然物の起源
A taxane derivative, cephalomannine occurs in the extract of Cephalotaxus rnannii. It has
been obtained as colourless needles from MeOH aq. and is laevorotatory with a specific rotation of [α]D -41° (MeOH).
使用
Cephalomannine is an active anti-cancer agent obtained from Taxus yunnanensis and has an antineoplastic effect on tumors found in mice. Cephalomannine is a chemotherapy drug that is given as a treatment for some types of cancer. Cephalomannine is most com
セファロマンニン 上流と下流の製品情報
原材料
準備製品
セファロマンニン 生産企業
Global( 312)Suppliers
71610-00-9(セファロマンニン)キーワード:
バッカチンIII
オマセタキシンメペスクシナート
(1S,3aR,14bβ)-1,5,6,8,9,14b-ヘキサヒドロ-2-メトキシ-4H-シクロペンタ[a][1,3]ジオキソロ[4,5-h]ピロロ[2,1-b][3]ベンゾアゼピン-1α-オール
7-EPI-セファロマンニン
7- エピタキソール
N-メチルタキソールC
7-EPI-10-デアセチルタキソール
10-デアセチルタキソール
イソセファロマンニン
タキソールC
タキソールベンジルアナログ
パクリタキセル
パクリタキセル-D5
5β,20-エポキシタキサ-11-エン-1,2α,4,7β,9α,10β,13α-ヘプタオール2-ベンゾアート4,7,9,10,13-ペンタアセタート
10-デアセチルバッカチンV
10-デアセチルバッカチンIII
10-デアセチル-13-オキソバッカチンIII
ジヒドロセファロマンニン, 2',3'-
- 71610-00-9
- TAXOL B
- BENZENEPROPANOICACID,ALPHA-HYDROXY-BETA-[(2-METHYL-1-OXO-2-BUTENYL)AMINO]-,6,12B-BIS(ACETYLOXY)-12-(BENZOYLOXY)-2A,3,4,4A,5,6,9,10,11,12,12A,12B-DODECAHYDRO-4,11-DIHYDROXY-4A,8,13,13-TETRAMETHYL-5-OXO-7,11-METHANO-1H-CYCLODECA[3,4]BENZ[1,2-
- BENZENEPROPANOIC ACID, ALPHA-HYDROXY-BETA-[(2-METHYL-1-OXO-2-BUTENYL)AMINO]-,6,12B-BIS(ACETYLOXY)-12-(BENZOYLOXY)-2A,3,4,4A,5,6,9,10,11,12,12A,12B-DODECAHYDRO-4,11-DIHYDROXY-4A,8,13,13-TETRAMETHYL-5-OXO-7,11-METHANO-1H-CYCLODECA[3,4]BENZ[1,2-B]OXET-9-YL ESTER,[2AR-[2A,4,4A,6,9[R*,S*(E)],11,12,12A,12B]]-
- CEPHALOMANNINE
- paclitaxel iMpurity I
- CephaloMannine, froM Taxus chinensis
- (αR,βS)-α-Hydroxy-β-[[(2E)-2-Methyl-1-oxo-2-buten-1-yl]aMino]benzenepropanoic Acid (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-
12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetraMethyl-5-oxo-7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester
- NSC 318735
- Benzenepropanoic acid, α-hydroxy-β-[[(2E)-2-methyl-1-oxo-2-buten-1-yl]amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-
- Paclitaxel Related Compound A (20 mg) (Ce-phalomannine)
- Paclitaxel Related CoMpound A
- CEPHALOMANNINE (TAXOL B)
- CEPHALOMANNINE:BENZENEPROPANOICACID, -HYDROXY--[(2-METHYL-1-OXO-2-BUTENYL)AMINO]-,6,12B-BIS(ACETYLOXY)-12-(BENZOYLOXY)-2A,3,4,4A,5,6,9,10,11,12,12A,12B-DODECAHYDRO-4,11-DIHYDROXY-4A,8,13,13-TETRAMETHYL-5-OXO-7,11-METHANO-1H-CYCLODECA[3,4]BENZ[1,2-B]OX...
- -[(2-methyl-1-oxo-2-butenyl)amino]-,6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-ylester,[2aR-[2aα,4β,4aβ,6β,9α[αR*,βS*(E)],11α,12α,12aα,12bα]]-
- Benzenepropanoicacid, α-hydroxy-β
- CEPHALOMANNINE:BENZENEPROPANOICACID, -HYDROXY--[(2-METHYL-1-OXO-2-BUTENYL)AMINO]-,6,12B-BIS(ACETYLOXY)-12-(BENZOYLOXY)-2A,3,4,4A,5,6,9,10,11,12,12A,12B-DODECAHYDRO-4,11-DIHYDROXY-4A,8,13,13-TETRAMETHYL-5-OXO-7,11-METHANO-1H-CYCLODECA[3,4]BENZ[1
- CEPHALOMANNINE(P)
- Paclitaxel EP Impurity B
- N-Debenzoyl-N-tigloylpaclitaxel
- Cephalomannine, 98%, from Taxus chinensis (Pilg.) Rehder
- N-debenzoyl-N-tigloylpaclitaxel (cephalomannine)
- Paclitaxel Related Compound A (Cephalomannine)
- Paclitaxel Impurity 2（Paclitaxel EP Impurity B）
- Cephalomannine 71610-00-9
- Paclitaxel Impurity Ⅰ:Cephalomannine
- Paclitaxel EP Impurity B
N-debenzoyl-N-tigloylpaclitaxel (cephalomannine)
- Cephalomannine, >99%
- N-Debenzoyl-N-tigloylpaclitaxel (Ce
- Benzenepropanoic acid, α-hydroxy-β-[[(2E)-2-methyl-1-oxo-2-buten-1-yl]amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, ...
- 3′-N-(trans-2-methyl-2-butenoyl)-3′-N-debenzoylpaclitaxel
- セファロマンニン
- PACLITAXEL RELATED COMPOUND A (セファロマンニン)
- タキソールB